Replies to post #299837 on Amarin Corp Plc (AMRN)

[Freifaller]

We rise slower than generic lovaza and we lose more, than generic lovaza. Pathetic...

PS: Thanks Tucaman

[invest2992]

Thanx for scripts. It is disappointing to see L+GL outperform V in percentage terms. Our momentum has really slowed down. At least half if not all the L scripts should be written for V. Granted pricing and insurance is an issue, but some people are able to get 3 mo. supply for $9. As long as we are doing DTC and no one is advertising L, we should be doing a lot better than L. But thanx again.

[circuitcity]

Thanks a lot, tucaman for continuing the effort since we are still in this investment.

This script is just depressing. This is a very alarming for two things: first the sales troop and dtc in US are not working well, how much longer do they need? Until burn out the cash on hand?

Sec. we all know even JT agrees Eu is much harder to deal with, then this performance in US is a indication for Eu, not pretty. This is why market is valuing amrn so low.

[Hondo1021]

Thanks tucaman. Decent for a Holiday week in a pandemic. Next week will be better.

[tucaman]

Scripts for week ending 09/18/2020
Below the updated script numbers. I included scripts for Lovaza (incl. Generic, though not sure I captured all suppliers) - for reference. I'll leave it to RAF and Sam to comment on plausibility of the figures.

Note that this was a holiday week.

Vascepa
TRx: 92'219 (+7.63%)
NRx: 43'026 (+11.05%)

Generic Lovaza
TRx: 64'583 (+8.24%)
NRx: 32'500 (+13.80%)